Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nano-PSO in Patients With Parkinson's Disease: Clinical Efficacy and Results in Molecular Imaging.

NCT05142085 is registered in ClinicalTrials.gov with Distribuidora Biolife SA de CV as lead sponsor.

NCT NCT05142085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nano-PSO in Patients With Parkinson's Disease: Clinical Efficacy and Results in Molecular Imaging.
Lead sponsor
Distribuidora Biolife SA de CV
Phase
Not applicable
Overall status
Unknown status
Start date
September 20, 2021
Completion date
June 30, 2023
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease